Deleted
Deleted Member
Posts: 0
|
Post by Deleted on Sept 1, 2016 13:45:16 GMT -5
The MannKind saga exemplifies Good versus Evil. Alfred Mann spent the majority of his life creating products for the betterment of mankind. Now with his greatest invention Afrezza and Technosphere, Wall Street is determined to bankrupt the company. Sad, very sad. I've thought a lot about exactly what you've stated - good versus evil when it comes to the stock market. So many ways to look at this situation. So many lenses to use. If I were to look at it as a human being without worldly influences, I feel this is definitely along the lines of evil. People making an intentional concerted effort to make sure afrezza does not catch on when obviously afrezza is and would be good for a lot of diabetics is not "good" (as compared to evil). Those who are responsible for their business interests are concerned about loss of revs for their products (mnkd competition) and those who make money on short term price movements and through market manipulation (hedge funds, etc). Under that lens, this is brutal for sure but I don't view it as evil, just part of the reality we live in. When I look at it through the lens of an investor, I don't see any of that. I see cash flow, balance sheets, sales, marketing, marketplace opportunities, insurance coverage, management, etc. Short term fluctuations mean very little to me and I prefer to focus on my investment rather than fringe floaters that won't likely impact my long term investment goals. From my experience I've separated out the evil and the competition/market manipulation from the investment. While the competition is an important factor to keep in consideration, I wouldn't be investing in a company if I didn't believe they couldn't hold their own. And that's as far as I take the competition factor. So when I say it's all about sales with mnkd, I believe it as much today as I did five minutes after FDA approval. The evil side and the competitive/manipulation side are not my concerns as there's nothing I can do about those sides. What I do know is this - if my company that I've invested in is doing their job, the company should/will do fine in the long run and as an investor, that's all I care about. And that's why it's all about the sales and not much else. Unlike many others, I accept the evil, the manipulation, the competition, the naysayers as much as I accept all other posts. But I don't dwell there nor do I dwell in the kool-aid side of the equation. When it comes to my finances, I'm definitely arrogant, to say the least. Self protection mechanism after several experiences early in my investing career where I followed the crowd over financial cliffs. |
|
|
|
Post by LosingMyBullishness on Sept 1, 2016 17:46:01 GMT -5
I find it interesting that when someone points out that corruption and greed permeate the market, a chorus of replies often ensues suggesting that it is a company's fault for not anticipating and overcoming that corruption and greed— as though one should just regard such a state as the acceptable status quo. I don't believe Kastanes mentioned in his original post that it was Wall Street's fault that the company is a penny stock. He stated an opinion about a sad market characteristic that many share and lament. Al Mann had a beneficent vision; but often, it seems, no good deed goes unpunished. It is true that if we live in resignation that things will never change, whether in the market or in other facets of society, that belief will become a self-fulfilling prophecy. Is that not a CEO's job? Every CEO has to deal with Wall St. and competition and yes MNKD probably more than others but it is their job. I'm not saying management should have anticipated everything that has happened to them but their job (specifically small bio-tech where cash will make or break you) is to have a plan for every angle and adapt to any scenario. A plan for everything? Which I assume means a solution for everything. Well, that's simple. 42. Sorry, thought you wanted to make a funny remark. |
|
Deleted
Deleted Member
Posts: 0
|
Post by Deleted on Sept 1, 2016 19:05:27 GMT -5
I find it interesting that when someone points out that corruption and greed permeate the market, a chorus of replies often ensues suggesting that it is a company's fault for not anticipating and overcoming that corruption and greed— as though one should just regard such a state as the acceptable status quo. I don't believe Kastanes mentioned in his original post that it was Wall Street's fault that the company is a penny stock. He stated an opinion about a sad market characteristic that many share and lament. Al Mann had a beneficent vision; but often, it seems, no good deed goes unpunished. It is true that if we live in resignation that things will never change, whether in the market or in other facets of society, that belief will become a self-fulfilling prophecy. Is that not a CEO's job? Every CEO has to deal with Wall St. and competition and yes MNKD probably more than others but it is their job. I'm not saying management should have anticipated everything that has happened to them but their job (specifically small bio-tech where cash will make or break you) is to have a plan for every angle and adapt to any scenario.— First you say, "I'm not saying management should have anticipated everything that has happened to them", and then you conclude with, "but their job is to have a plan for every angle and adapt to any scenario." You are condradicting yourself here. So which is it? |
|
